$0.24
-0.03 (-11.67%)
Open$0.29
Previous Close$0.27
Day High$0.29
Day Low$0.21
52W High$19.20
52W Low$0.27
Volume—
Avg Volume299.4K
Market Cap2.07M
P/E Ratio—
EPS$-8.06
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+20,117.5% upside
Current
$0.24
$0.24
Target
$48.34
$48.34
$29.39
$48.34 avg
$58.89
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.75M | 1.85M | 1.56M |
| Net Income | -488,923 | -548,272 | -518,591 |
| Profit Margin | -27.9% | -29.7% | -33.3% |
| EBITDA | -843,788 | -899,520 | -655,593 |
| Free Cash Flow | -343,922 | -223,177 | -234,743 |
| Rev Growth | +4.0% | +6.5% | +13.9% |
| Debt/Equity | 0.91 | 0.97 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |